Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination with 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study

Clinical Infectious Diseases

Volumn 67, Issue 8, 2018, Pages 1213-1219

  Sigurdsson, Samuel ^a   Eythorsson, Elias ^a   Hrafnkelsson, Birgir ^a   Erlendsdóttir, Helga ^a,b   Kristinsson, Karl G ^a,b   Haraldsson, Ásgeir ^a,c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Department of Clinical Microbiology ^*  (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

acute otitis media; herd effect; PCV 10; pneumococcal vaccination; vaccine impact

Indexed keywords

10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE;

FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; HERD IMMUNITY; HUMAN; ICELAND; INFANT; ISOLATION AND PURIFICATION; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; ICELAND; IMMUNITY, HERD; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PRIMARY HEALTH CARE; PUBLIC HEALTH SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 85053715581     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy233     Document Type: Article

References (40)

1. Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One 2012; 7:e36226
2. Liese JG, Silfverdal SA, Giaquinto C, et al. Incidence and clinical presentation of acute otitis media in children aged 6 years in European medical practices. Epidemiol Infect 2014; 142:1778-88
3. Usonis V, Jackowska T, Petraitiene S, et al. Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC Pediatr 2016; 16:108
4. Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr 2014; 168:68-75
5. Ahmed S, Shapiro NL, Bhattacharyya N. Incremental health care utilization and costs for acute otitis media in children. Laryngoscope 2014; 124:301-5
6. Gudnason T, Hrafnkelsson B, Laxdal B, Kristinsson KG. Does hygiene intervention at day care centres reduce infectious illnesses in children? An intervention cohort study. Scand J Infect Dis 2013; 45:397-403
7. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160:83-94
8. Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics 2017;140:e20170181
9. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J 2004; 23:1142-52
10. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992; 11:S7-11
11. Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review. PLoS One 2016;11:e0150949
12. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23:824-8
13. Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 2016; 16:480-92
14. Van Eldere J, Slack MP, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 2014; 14:1281-92
15. O'Brien KL, David AB, Chandran A, et al. Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants. Pediatr Infect Dis J 2008; 27:71-3
16. Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med 2014;11:e1001657
17. Saez-Llorens X, Rowley S, Wong D, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children-A randomized controlled trial. Hum Vaccin Immunother 2017; 13:1-16
18. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367:740-8
19. Vesikari T, Forsten A, Seppa I, et al. Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-A double-blind randomized clinical trial in Finland. J Pediatric Infect Dis Soc 2016;5:237-48
20. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003; 22:10-6
21. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media. Clin Infect Dis 2016; 63:611-8
22. Magnus MC, Vestrheim DF, Nystad W, et al. Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination. Pediatr Infect Dis J 2012; 31:951-5
23. Lau WC, Murray M, El-Turki A, et al. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine 2015; 33:5072-9
24. Taylor S, Marchisio P, Vergison A, Harriague J, Hausdorff WP, Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis 2012; 54:1765-73
25. Sartori AL, Minamisava R, Bierrenbach AL, et al. Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil. PLoS One 2017; 12:e0179222
26. Howitz MF, Harboe ZB, Ingels H, Valentiner-Branth P, Molbak K, Djurhuus BD. A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014. Vaccine 2017; 35:5858-63
27. Eyporsson E, Erlendsdottir H, Kristinsson KG, Guonason P, Haraldsson A. High uptake of pneumococcal conjugate vaccine (PHID-CV10) in the vaccination program in Iceland. In: European Society for Paediatric Infectious Diseases Annual Meeting, Madrid, Spain, 2017
28. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer-Verlag, 2000:350
29. Cook RJ, Richard J, Lawless JF. The statistical analysis of recurrent events. New York: Springer-Verlag, 2007:403
30. Hadley J. Sicker and poorer\-The consequences of being uninsured: a review of the research on the relationship between health insurance, medical care use, health, work, and income. Med Care Res Rev 2003; 60:3S-75S; discussion 76S-112S
31. Smolderen KG, Spertus JA, Nallamothu BK, et al. Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction. JAMA 2010; 303:1392-400
32. Organisation for Economic Co-operation and Development Family Database. OECD Social Policy Division, Directorate of Employment, Labour and Social Affairs PF3.2: enrolment in childcare and pre-school. Available at: http://www. oecd.org/els/family/database.htm. Accessed 23 September 2017
33. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997; 99:318-33
34. Ramakrishnan K, Sparks RA, Berryhill WE. Diagnosis and treatment of otitis media. Am Fam Physician 2007; 76:1650-8
35. Sigurdsson S, Erlendsdottir H, Quirk SJ, et al. Pneumococcal vaccination: direct and herd effect on carriage of vaccine types and antibiotic resistance in Icelandic children. Vaccine 2017; 35:5242-8
36. Marchisio P, Cantarutti L, Sturkenboom M, et al; Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database. BMC Pediatr 2012; 12:185
37. Gribben B, Salkeld LJ, Hoare S, Jones HF. The incidence of acute otitis media in New Zealand children under five years of age in the primary care setting. J Prim Health Care 2012; 4:205-12
38. Nicholls TR, Leach AJ, Morris PS. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: systematic review and meta-analyses of randomised controlled trials. Vaccine 2016; 34:703-13
39. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J 2014; 33(Suppl 2):S161-71
40. Directorate of Health, Iceland. Clinical guidelines for treatment of Acute Otitis Media [In Icelandic] 2009. Available at: https://www.landlaeknir.is/servlet/file/ store93/item2547/4241.pdf. Accessed 23 September 2017